NYCB Announces $1 Billion Capital Infusion and Reverse Stock Split
NYSE-listed New York Community Bancorp, Inc. (NYCB) has closed its previously announced capital infusion transaction, securing $1 billion in aggregate capital. As part of the transaction, NYCB has issued and sold 50 million shares of its common stock to a group of institutional investors at a price of $20.00 per share. Concurrently, NYCB has announced a one-for-five reverse stock split, which will become effective on February 28, 2023.
